Guardant Health says Shield reaches 80% of eligible adults

Guardant Health said Shield now reaches 80% of eligible adults, with Evernorth’s EviCore to cover the colorectal cancer Shield blood test for average-risk patients aged 45+ starting Jan. 1, 2027 across 23 states.